Meridian Bioscience Inc.

(VIVO) Trade

By |

Profile

Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment contributes the majority of revenue & manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.

Contact Information

Website: www.meridianbioscience.com
Email: mbi@meridianbioscience.com
Main Phone: +1 513 271-3700
Address: 3471 River Hills Drive
State: OH
City / Town: Cincinnati
Country: USA
Postal Code: 45244

Issuer Information

Exchange: NGS
CEO: Jack P. Kenny
Employees: 585
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)
$ 17.53 $ 0.18 (1.04%)
Last Price 17.53 Change $ 0.18 Change % 1.04 Tick N/A
Bid 15.50 Bid Size 200.00 Ask 19.50 Ask Size 300.00
Open 17.53 High 17.93 Low 17.37 Prev Close 17.35
Last Trade Volume 305,512 52 Wk Hi 19.84 52 Wk Low 13.53
Market Cap 743.3 mi Ex-Div Date Div Rate 0.50 Yield 2.8520
Shares 42,402,912.00 EPS (TTM) 0.56 PE Ratio 31.20 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 28
Number of Buys 0 13
Number of Sells 0 15
Net Activity 0 3821
Last 10 Buys Shares
John C. McIlwraith 1,000
John M. Rice 1,000
John A. Kraeutler 1,000
Melissa A. Lueke 1,000
John A. Kraeutler 1,000
Lawrence J. Baldini 1,000
John C. McIlwraith 1,000
Catherine A. Sazdanoff 1,000
John C. McIlwraith 1,000
Dwight E. Ellingwood 1,000
Last 10 Sell Shares
Vecheslav Elagin 1,000
Richard L. Eberly 1,000
Richard L. Eberly 1,000
Marviette D. Johnson 1,000
Susan D. Rolih 1,000
Richard L. Eberly 1,000
Melissa A. Lueke 1,000
John A. Kraeutler 1,000
Robert J. Ready 1,000
Vecheslav Elagin 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 17 17 17 16
Low Target Price Estimate 11 11 11 11
Mean Target Price Estimate 15 15 15 14.33
Standard Deviation 2.71 2.71 2.71 2.89
Date of Most Recent Estimate 04/04/18 04/04/18 04/04/18 03/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 3 3 4 5
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 2
Mean Rec. 3.5 3.5 3.4 3.57